Study S000550

Regimen Transition After Short-Term Intensive Insulin Therapy in Type 2 Diabetes Mellitus Patients With Inadequate Glycemic Control on Oral Hypoglycemic Agents: A Multicenter, Open-Label, Randomized Controlled Study

ClinicalTrials.gov record

Registration

Registration: NCT07173712
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Phase: PHASE4
Masking: NONE
Status: NOT_YET_RECRUITING
Enrollment: 324
Start: 2026-03-15
Primary completion: 2027-06-30
Lead sponsor: Yanbing Li
Conditions: Type 2 Diabetes
Interventions: DRUG:CSII; DRUG:Insulin glargine /lixisenatide Fixed Ratio Combination; DRUG:Insulin Degludec and Insulin Aspart Injection; DRUG:Insulin Glargine (HOE901 - U300); DRUG:Metformin
Results posted: FALSE

Registered primary outcomes

Proportion of subjects with optimal glycemic control [24 weeks]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.